Search results
Neurosurgeon
- David S. Baskin is a neurosurgeon who currently works at Houston Methodist Hospital as the Vice Chairman of the Department of Neurosurgery, the Director of the Residency Training program, and the Director of the Kenneth R. Peak Brain & Pituitary Tumor Center, and is also a professor of neurosurgery at Weill Cornell Medical College.
en.wikipedia.org/wiki/David_Baskin
People also ask
Who is Dr Baskin?
What did Dr Baskin do after completing a residency?
Where did Dr Baskin start his research career?
Did Dr Baskin treat a herniated disc?
David S. Baskin is a neurosurgeon who currently works at Houston Methodist Hospital as the Vice Chairman of the Department of Neurosurgery, the Director of the Residency Training program, and the Director of the Kenneth R. Peak Brain & Pituitary Tumor Center, and is also a professor of neurosurgery at Weill Cornell Medical College .
David S. Baskin, MD, FAANS, FACS is a Kenneth R. Peak Presidential Distinguished Chair & Program Director, Neurosurgery Residency, Depart at Houston Methodist and Weill Cornell Medical College - specializing in Stroke, Neurological surgery, Brain tumors.
- Courageous Patient and Family Help Advance Science
- A New Way to Attack Cancerous Glial Cells
- A Leap Forward in The Hunt For Less Toxic, More Effective Therapies
Unfortunately, the 53-year-old patient died following an unrelated injury about a month into the treatment. An autopsy confirmed that during that time, 31% of his brain tumor disappeared. Dr. Baskin thanked the family for agreeing to the autopsy, which he said made "an invaluable contribution" to the study and development of "this potentially power...
Because electromagnetic fields have been shown to produce anticancer effects in vitro — and treatment options and outcomes for glioblastoma have remained dismal despite more than 40 years of research — the FDA has approved treatment involving electric fields. Specially devised patterns of magnet rotations have shown strong, selective anticancer eff...
Glioblastoma is the most common brain malignancy and almost always lethal. It carries a life expectancy of a few months to two years. The standard of care consists of intense radiation and chemotherapy, which patients are frequently unable to complete due to their toxicity. The late Houston Methodist patient, for example, underwent radical surgical...
Oct 11, 2021 · Lance's glioblastoma shrunk by 30 percent in just six weeks. Dr. David Baskin and his team in the Peak Brain Tumor Center at Houston Methodist continue their research into this novel technology. This is Lance's story.
With Barry away this week, Ernest talks with Baskin Wealth Management's founder and Chairman, David Baskin about the story of Baskin and how wealth management has evolved. This episode is...
- 27 min
- Long Term Investing Podcast
Jan 1, 2001 · Dr. Baskin has recently developed methodologies to quantify the levels of different types of DNA damage and of labeled antibody staining in the field of fluorescence microscopy, using a new type of labeled tissue phantoms.
Cited by. Year. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the Second National Acute Spinal Cord Injury Study. MB...
